Self-Monitoring Blood Glucose Devices Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product Type (Blood Glucose Meters, Lancets, Test Strips, and Other Product Types); Application (Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes); End User (Hospitals & Clinics, Diagnostic Centers, Home Care Settings, and Other End Users), and Geography
Report Code: TIPRE00008684 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Diabetes is among the most commonly observed metabolic diseases found across the globe. Timely monitoring and tracking of blood glucose levels is an essential step in diabetes management. The level of blood glucose of a patient can be effectively monitored using blood glucose monitoring devices. With rise in the awareness regarding the necessity to manage ones glucose levels, the use of self-monitoring blood glucose devices has increased over the years, leading to relative growth of the market.
MARKET DYNAMICS
The self-monitoring blood glucose devices market is anticipated to grow in the forecast, owing to increase in prevalence of diabetes, along with the rise in obese population. Also, the adoption of sedentary lifestyle, coupled with rising geriatric population is anticipated to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Self-Monitoring Blood Glucose Devices Market Analysis to 2028" is a specialized and in-depth study of the medical devices industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the self-monitoring blood glucose devices market with detailed market segmentation by product type, application, end user, and geography. The self-monitoring blood glucose devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading self-monitoring blood glucose devices market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The self-monitoring blood glucose devices market is segmented based on product type, application and end user. Based on product type, the market is segmented as blood glucose meters, lancets, test strips, and other product types. Based on the application, the market is classified as type 1 diabetes, type 2 diabetes and gestational diabetes. Similarly, based on the end user, the market is categorized as hospitals & clinics, diagnostic centers, home care settings, and other end users.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the self-monitoring blood glucose devices market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The self-monitoring blood glucose devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting self-monitoring blood glucose devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the self-monitoring blood glucose devices market in these regions.
The report covers key developments in the self-monitoring blood glucose devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from self-monitoring blood glucose devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for self-monitoring blood glucose devices market in the global market. Below mentioned is the list of few companies engaged in the self-monitoring blood glucose devices market.
The report also includes the profiles of key self-monitoring blood glucose devices market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories Limited
- ALLMEDICUS
- ARKRAY, Inc.
- Ascensia Diabetes Care Holdings AG
- B. Braun Melsungen AG
- Bionime Corporation
- Dexcom, Inc.
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson Services, Inc.
- Nova Biomedical
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Diabetes is among the most commonly observed metabolic diseases found across the globe. Timely monitoring and tracking of blood glucose levels is an essential step in diabetes management. The level of blood glucose of a patient can be effectively monitored using blood glucose monitoring devices. With rise in the awareness regarding the necessity to manage ones glucose levels, the use of self-monitoring blood glucose devices has increased over the years, leading to relative growth of the market.
MARKET DYNAMICS
The self-monitoring blood glucose devices market is anticipated to grow in the forecast, owing to increase in prevalence of diabetes, along with the rise in obese population. Also, the adoption of sedentary lifestyle, coupled with rising geriatric population is anticipated to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Self-Monitoring Blood Glucose Devices Market Analysis to 2028" is a specialized and in-depth study of the medical devices industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the self-monitoring blood glucose devices market with detailed market segmentation by product type, application, end user, and geography. The self-monitoring blood glucose devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading self-monitoring blood glucose devices market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The self-monitoring blood glucose devices market is segmented based on product type, application and end user. Based on product type, the market is segmented as blood glucose meters, lancets, test strips, and other product types. Based on the application, the market is classified as type 1 diabetes, type 2 diabetes and gestational diabetes. Similarly, based on the end user, the market is categorized as hospitals & clinics, diagnostic centers, home care settings, and other end users.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the self-monitoring blood glucose devices market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The self-monitoring blood glucose devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting self-monitoring blood glucose devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the self-monitoring blood glucose devices market in these regions.
The report covers key developments in the self-monitoring blood glucose devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from self-monitoring blood glucose devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for self-monitoring blood glucose devices market in the global market. Below mentioned is the list of few companies engaged in the self-monitoring blood glucose devices market.
The report also includes the profiles of key self-monitoring blood glucose devices market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories Limited
- ALLMEDICUS
- ARKRAY, Inc.
- Ascensia Diabetes Care Holdings AG
- B. Braun Melsungen AG
- Bionime Corporation
- Dexcom, Inc.
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson Services, Inc.
- Nova Biomedical
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
The List of Companies
1. Abbott Laboratories Limited
2. ALLMEDICUS
3. ARKRAY, Inc.
4. Ascensia Diabetes Care Holdings AG
5. B. Braun Melsungen AG
6. Bionime Corporation
7. Dexcom, Inc.
8. F. Hoffmann-La Roche Ltd
9. Johnson & Johnson Services, Inc.
10. Nova Biomedical
1. Abbott Laboratories Limited
2. ALLMEDICUS
3. ARKRAY, Inc.
4. Ascensia Diabetes Care Holdings AG
5. B. Braun Melsungen AG
6. Bionime Corporation
7. Dexcom, Inc.
8. F. Hoffmann-La Roche Ltd
9. Johnson & Johnson Services, Inc.
10. Nova Biomedical
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount